>

New Nasal Sprays Offer Hope for Preventing and Treating Respiratory Viruses

Groundbreaking Research at University of Houston Yields Promising Results

Unveiling a Novel Approach to Combatting Respiratory Infections

In a groundbreaking scientific breakthrough, researchers at the University of Houston have developed two groundbreaking nasal sprays that have the potential to revolutionize the fight against respiratory viruses. These innovative sprays, known as WEB NanoSTING and WEB NanoSTING-SN, offer a promising solution for preventing and treating a wide range of respiratory infections, including those caused by COVID-19 and influenza.

WEB NanoSTING, the first of these remarkable nasal sprays, is designed to activate the body's natural immune system, putting cells on high alert to combat potential infections. By stimulating the production of interferons, proteins that act as the body's first line of defense against viruses, WEB NanoSTING helps the immune system swiftly and effectively fend off pathogens.

WEB NanoSTING-SN, the second nasal spray developed by the research team, takes a complementary approach. It targets a specific protein known as SNAP-23, which plays a crucial role in the life cycle of respiratory viruses. By inhibiting SNAP-23, WEB NanoSTING-SN disrupts the virus's ability to replicate and spread, providing an additional layer of protection against infection.